|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.900 CNY | -10.06% |
|
-7.52% | -19.95% |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 07/05 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 606.14Cr 89Cr 78Cr 72Cr 66Cr 125.28Cr 8.61TCr 128.06Cr 861.93Cr 339.02Cr 4.22TCr 335.83Cr 328.46Cr 15TCr | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 492Cr 73Cr 63Cr 59Cr 54Cr 101.69Cr 6.99TCr 103.95Cr 699.63Cr 275.18Cr 3.42TCr 272.6Cr 266.62Cr 12TCr | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -10.06% | ||
| 1 week | -7.52% | ||
| Current month | -0.51% | ||
| 1 month | +17.30% | ||
| 3 months | -22.37% | ||
| 6 months | -22.16% | ||
| Current year | -19.95% |
| 1 week | 5.9 |  | 7.33 |
| 1 month | 4.81 | | 7.33 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 3,40,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.06% | -7.52% | -24.46% | -40.22% | 99Cr | |
| +0.85% | -0.80% | +54.84% | +163.70% | 1,04300Cr | |
| +1.23% | -1.53% | +55.26% | +59.07% | 60TCr | |
| +0.04% | +2.58% | +32.96% | +88.75% | 45TCr | |
| +0.78% | -0.71% | +30.04% | +24.61% | 33TCr | |
| +1.41% | +0.58% | +33.92% | +47.20% | 28TCr | |
| -0.27% | -1.87% | +22.13% | +23.47% | 26TCr | |
| -1.76% | +2.37% | -22.19% | -38.45% | 23TCr | |
| -1.42% | +0.80% | +22.81% | +60.77% | 20TCr | |
| -1.48% | +3.43% | +23.42% | +73.31% | 17TCr | |
| Average | -1.11% | -0.67% | +22.87% | +46.22% | 35.62TCr | |
| Weighted average by Cap. | +0.20% | +0.04% | +37.57% | +81.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 66Cr 9.74Cr 8.51Cr 7.86Cr 7.24Cr 14Cr 938.29Cr 14Cr 94Cr 37Cr 459.54Cr 37Cr 36Cr 1.58TCr | 62Cr 9.2Cr 8.04Cr 7.42Cr 6.84Cr 13Cr 886.04Cr 13Cr 89Cr 35Cr 433.95Cr 35Cr 34Cr 1.49TCr |
| Net income | -7.41Cr -1.09Cr -95.49L -88.12L -81.22L -1.53Cr -105.23Cr -1.56Cr -11Cr -4.14Cr -52Cr -4.1Cr -4.01Cr -177.41Cr | -35Cr -5.12Cr -4.48Cr -4.13Cr -3.81Cr -7.18Cr -493.28Cr -7.34Cr -49Cr -19Cr -241.59Cr -19Cr -19Cr -831.67Cr |
| Net Debt | -198.23Cr -29Cr -26Cr -24Cr -22Cr -41Cr -2.82TCr -42Cr -281.88Cr -110.87Cr -1.38TCr -109.83Cr -107.42Cr -4.75TCr | -114.13Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.62TCr -24Cr -162.3Cr -64Cr -794.17Cr -63Cr -62Cr -2.73TCr |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | CN¥5.900 | -10.06% | 8,83,65,522 |
| 16/26/16 | CN¥6.560 | -1.94% | 10,02,39,752 |
| 15/26/15 | CN¥6.690 | -5.11% | 13,79,47,653 |
| 14/26/14 | CN¥7.050 | +4.91% | 11,58,89,137 |
| 13/26/13 | CN¥6.720 | +5.33% | 11,62,26,817 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
